Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001638599-17-000352
Filing Date
2017-04-05
Accepted
2017-04-05 16:58:31
Documents
1
Period of Report
2014-09-05

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT doc4_4655.html 4  
1 PRIMARY DOCUMENT doc4_4655.xml 4 6001
  Complete submission text file 0001638599-17-000352.txt   7535
Mailing Address 9 INNOVATION WAY, SUITE 100 NEWARK DE 19711
Business Address 9 INNOVATION WAY, SUITE 100 NEWARK DE 19711 302 355-0650
iBio, Inc. (Issuer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O IBIO, INC. 9 INNOVATION WAY, SUITE 100 NEWARK DE 19711
Business Address
RUSSELL PHILIP K. (Reporting) CIK: 0001486819 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35023 | Film No.: 17743240